Literature DB >> 30497668

Mycosis Fungoides and Sézary Syndrome: An Update.

Cecilia Larocca1, Thomas Kupper2.   

Abstract

Cutaneous T-cell lymphomas are a heterogeneous collection of non-Hodgkin lymphomas that arise from skin-tropic memory T lymphocytes. Among them, mycosis fungoides (MF) and Sézary syndrome (SS) are the most common malignancies. Diagnosis requires the combination of clinical, pathologic, and molecular features. Significant advances have been made in understanding the genetic and epigenetic aberrations in SS and to some extent in MF. Several prognostic factors have been identified. The goal of treatment is to minimize morbidity and limit disease progression. However, hematopoietic stem cell transplantation, considered for patients with advanced stages, is the only therapy with curative intent.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cause; Cutaneous T-cell lymphoma; Diagnosis; Genetics; Mycosis fungoides; Review; Sézary syndrome; Therapy

Mesh:

Year:  2019        PMID: 30497668      PMCID: PMC7147244          DOI: 10.1016/j.hoc.2018.09.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  64 in total

Review 1.  Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies.

Authors:  Judah J Mirvish; Rebecca G Pomerantz; Louis D Falo; Larisa J Geskin
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

2.  Alemtuzumab therapy for leukemic cutaneous T-cell lymphoma: diffuse erythema as a positive predictor of complete remission.

Authors:  Rei Watanabe; Jessica E Teague; David C Fisher; Thomas S Kupper; Rachael A Clark
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

3.  Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.

Authors:  Rei Watanabe; Ahmed Gehad; Chao Yang; Laura L Scott; Jessica E Teague; Christoph Schlapbach; Christopher P Elco; Victor Huang; Tiago R Matos; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2015-03-18       Impact factor: 17.956

4.  Highly Sensitive Virome Capture Sequencing Technique VirCapSeq-VERT Identifies Partial Noncoding Sequences but no Active Viral Infection in Cutaneous T-Cell Lymphoma.

Authors:  Mary E Anderson; Dorottya Nagy-Szakal; Komal Jain; Christina C Patrone; Mark G Frattini; W Ian Lipkin; Larisa J Geskin
Journal:  J Invest Dermatol       Date:  2018-02-07       Impact factor: 8.551

Review 5.  European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Authors:  Franz Trautinger; Johanna Eder; Chalid Assaf; Martine Bagot; Antonio Cozzio; Reinhard Dummer; Robert Gniadecki; Claus-Detlev Klemke; Pablo L Ortiz-Romero; Evangelia Papadavid; Nicola Pimpinelli; Pietro Quaglino; Annamari Ranki; Julia Scarisbrick; Rudolf Stadler; Liisa Väkevä; Maarten H Vermeer; Sean Whittaker; Rein Willemze; Robert Knobler
Journal:  Eur J Cancer       Date:  2017-03-31       Impact factor: 9.162

6.  Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.

Authors:  P L Zinzani; G Baliva; M Magagnoli; M Bendandi; G Modugno; F Gherlinzoni; G F Orcioni; S Ascani; R Simoni; S A Pileri; S Tura
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.

Authors:  Elena Netchiporouk; Ivan V Litvinov; Linda Moreau; Martin Gilbert; Denis Sasseville; Madeleine Duvic
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

Authors:  P L Zinzani; F Venturini; V Stefoni; M Fina; C Pellegrini; E Derenzini; L Gandolfi; A Broccoli; L Argnani; F Quirini; S Pileri; M Baccarani
Journal:  Ann Oncol       Date:  2009-11-03       Impact factor: 32.976

9.  Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.

Authors:  Pier Luigi Zinzani; Gerardo Musuraca; Monica Tani; Vittorio Stefoni; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Antonio de Vivo; Elena Sabattini; Stefano Pileri; Michele Baccarani
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

10.  TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.

Authors:  Emmanuella Guenova; Rei Watanabe; Jessica E Teague; Jennifer A Desimone; Ying Jiang; Mitra Dowlatshahi; Christoph Schlapbach; Knut Schaekel; Alain H Rook; Marianne Tawa; David C Fisher; Thomas S Kupper; Rachael A Clark
Journal:  Clin Cancer Res       Date:  2013-06-19       Impact factor: 12.531

View more
  16 in total

1.  Need for Expansion of Coverage for Narrowband UVB Phototherapy in Mycosis Fungoides and Sézary Syndrome.

Authors:  Agnes Kim; Amelia Insley; Lindsey West; Heather Woodworth Goff
Journal:  Am Health Drug Benefits       Date:  2021-12

2.  Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement: A case report.

Authors:  Yan-Wei Chen; Hai-Zhen Yang; Shuang-Shuang Zhao; Zheng Zhang; Zhe-Ming Chen; Hua-Hui Feng; Mao-Hui An; Ke-Ke Wang; Ran Duan; Bao-Ding Chen
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Mycosis fungoides and Sézary syndrome.

Authors:  Constanze Jonak; Julia Tittes; Patrick Manfred Brunner; Emmanuella Guenova
Journal:  J Dtsch Dermatol Ges       Date:  2021-09       Impact factor: 5.231

4.  Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma.

Authors:  Jennifer A Salant; Niloufer Khan; Judith E Nelson; Moe Norton-Westbrook; Anjali V Desai
Journal:  J Palliat Med       Date:  2021-12-31       Impact factor: 2.947

5.  Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis.

Authors:  Florentia Dimitriou; Urs Schanz; Gayathri Nair; Susanne Kimeswenger; Marie-Charlotte Brüggen; Wolfram Hoetzenecker; Lars E French; Reinhard Dummer; Antonio Cozzio; Emmanuella Guenova
Journal:  Front Med (Lausanne)       Date:  2020-06-25

6.  Mycosis Fungoides Palmaris et Plantaris on the Plantar Aspect of the Foot: A Case Report.

Authors:  Ian Beiser; Joon Yim; Erin Robles-Sherman; Gene S Mirkin; Xingpei Hao
Journal:  Am J Case Rep       Date:  2020-09-18

7.  Predictive modeling of clinical trial terminations using feature engineering and embedding learning.

Authors:  Magdalyn E Elkin; Xingquan Zhu
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

8.  Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center.

Authors:  Subuhi Kaul; Micah Belzberg; John-Douglas Matthew Hughes; Varun Mahadevan; Raveena Khanna; Pegah R Bakhshi; Michael S Hong; Kyle A Williams; Annie L Grossberg; Shawn G Kwatra; Ronald J Sweren
Journal:  Medicines (Basel)       Date:  2019-12-26

9.  Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro.

Authors:  Catalina Silva-Hirschberg; Hannah Hartman; Samantha Stack; Steve Swenson; Radu O Minea; Michael A Davitz; Thomas C Chen; Axel H Schönthal
Journal:  Ther Adv Med Oncol       Date:  2019-12-06       Impact factor: 8.168

10.  Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.

Authors:  Antonio Travaglino; Silvia Varricchio; Massimo Mascolo; Daniela Russo; Elena Sabattini; Claudio Agostinelli; Clara Bertuzzi; Antonello Baldo; Alessandro Pileri; Marco Picardi; Fabrizio Pane; Stefania Staibano
Journal:  Virchows Arch       Date:  2020-10-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.